Access ISN-ACT Webinar on Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors
Did you miss the live session? A recording is available here.
Professor Meg Jardine, ISN-ACT (Advancing Clinical Trials) Committee chair, and speakers David Wheeler, Jonathan Barratt and Jodie Babitt joined in a lively discussion on this treatment option and on the management of anemia in CKD patients.
This webinar is supported by Astellas.